Literature DB >> 27521571

Tanshinone IIA sensitizes oral squamous cell carcinoma to radiation due to an enhanced autophagy.

Lijuan Ding1, Shudong Wang2, Xiaozhang Qu3, Jiafeng Wang4.   

Abstract

PURPOSE: Tanshinone IIA (TanIIA), which is derived from the roots of Salvia miltiorrhiza (Danshen), has multiple pharmacological activities. However, the radiosensitivezing activity of TanIIA in oral cancer cells has not been studied extensively. The purpose of this study is to investigate the radiosensitizing effects of TanIIA in human oral squamous cell carcinoma SCC090 and examined the underlying mechanisms.
METHODS: Clonogenic assay was used to investigate the radiosensitizing effect of TanIIA on SCC090. And then, apoptosis and reactive oxygen species (ROS) induced by the combination of TanIIA with radiation were analyzed by Flow cytometry. Finally, autophagy was detected by monodansylcadervarine (MDC) staining.
RESULTS: TanIIA could significantly sensitize SCC090 to radiation. Meanwhile, an increase ROS generation after exposed to the combination treatment was found. In addition, the protein levels of Beclin 1, Atg5 and LC3-II, three important proteins involved in autophagy were increased in cells.
CONCLUSIONS: TanIIA exerted a strong radiosensitizing effect on SCC090 comparing with the simple drug or single radiation treatment, which was due to an enhanced ROS generation and autophagy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; Radiation; SCC090; Tanshinone IIA

Mesh:

Substances:

Year:  2016        PMID: 27521571     DOI: 10.1016/j.etap.2016.07.021

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  10 in total

1.  Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma.

Authors:  Wei Mao; Jian Ding; Yu Li; Ruofei Huang; Baoxin Wang
Journal:  Exp Ther Med       Date:  2022-06-16       Impact factor: 2.751

Review 2.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 3.  Natural agents mediated autophagic signal networks in cancer.

Authors:  Eun Jung Sohn; Hwan Tae Park
Journal:  Cancer Cell Int       Date:  2017-11-28       Impact factor: 5.722

4.  Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.

Authors:  Ye Qiu; Conghua Li; Qinhua Wang; Xingqi Zeng; Ping Ji
Journal:  Cancer Med       Date:  2018-01-06       Impact factor: 4.452

Review 5.  Traditional Herbal Medicine Mediated Regulations during Head and Neck Carcinogenesis.

Authors:  Xiang-Yun Lan; Tzu-Ting Chung; Chien-Ling Huang; Yi-Jang Lee; Wan-Chun Li
Journal:  Biomolecules       Date:  2020-09-15

6.  Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.

Authors:  Ming Li; Haidan Liu; Qin Zhao; Shuangze Han; Li Zhou; Wenbin Liu; Wei Li; Feng Gao
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

7.  Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.

Authors:  Lian Zheng; Zhen-Jie Guan; Wen-Ting Pan; Tian-Feng Du; Yu-Jia Zhai; Jia Guo
Journal:  Oncol Res       Date:  2017-05-21       Impact factor: 5.574

Review 8.  An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen).

Authors:  Irum Naz; Myriam Merarchi; Shanaya Ramchandani; Muhammad Rashid Khan; Muhammad Nouman Malik; Sumaira Sarwar; Acharan S Narula; Kwang Seok Ahn
Journal:  Explor Target Antitumor Ther       Date:  2020-06-29

Review 9.  Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes.

Authors:  Meng Lu; Xintian Lan; Xi Wu; Xiaoxue Fang; Yegang Zhang; Haoming Luo; Wenyi Gao; Donglu Wu
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

10.  Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway.

Authors:  I-Yun Lee; Yin-Yin Lin; Yao-Hsu Yang; Yu-Shin Lin; Chun-Liang Lin; Wei-Yu Lin; Yu-Ching Cheng; Li-Hsin Shu; Ching-Yuan Wu
Journal:  BMC Pharmacol Toxicol       Date:  2018-01-31       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.